🔴 Quantum BioPharma is trading 5% down today with no clear company-specific catalyst

Quantum BioPharma is trading 5.03% down at $3.12, with no clear company-specific catalyst identified for August 26, 2026.

• Recent updates—including lower second-quarter expenses, stronger liquidity, and FDA clearance to advance Lucid-MS into Phase 2—were announced earlier and do not directly explain the decline.
• Broader indexes are only modestly lower, while biotech is outperforming, so market or sector conditions do not clearly account for the move.
• The decline remains unexplained.